CUDC-427

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCUDC-427
Drug Alias NameCUDC-427GDC-0917RG-7459
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActioncIAP1/cIAP2 inhibitors
TargetscIAP1/cIAP2
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCuris Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech IncCuris Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursLymphoma

Other Information

ATC CodeN/A
Related LinksN/A